Microbiological  ||| S:0 E:16 ||| JJ
diagnosis  ||| S:16 E:26 ||| NN
of  ||| S:26 E:29 ||| IN
pneumonia  ||| S:29 E:39 ||| JJ
Pneumonia  ||| S:39 E:49 ||| NNP
is  ||| S:49 E:52 ||| VBZ
an  ||| S:52 E:55 ||| DT
importance  ||| S:55 E:66 ||| NN
cause  ||| S:66 E:72 ||| NN
of  ||| S:72 E:75 ||| IN
mortality  ||| S:75 E:85 ||| NN
and  ||| S:85 E:89 ||| CC
morbidity  ||| S:89 E:99 ||| NN
in  ||| S:99 E:102 ||| IN
adults ||| S:102 E:108 ||| NNS
.  ||| S:108 E:110 ||| .
Two  ||| S:110 E:114 ||| CD
types  ||| S:114 E:120 ||| NNS
of  ||| S:120 E:123 ||| IN
pneumonia  ||| S:123 E:133 ||| NNS
are  ||| S:133 E:137 ||| VBP
defined ||| S:137 E:144 ||| VBN
:  ||| S:144 E:146 ||| :
community-acquired  ||| S:146 E:165 ||| JJ
and  ||| S:165 E:169 ||| CC
nosocomial  ||| S:169 E:180 ||| JJ
pneumonia  ||| S:180 E:190 ||| NN
with  ||| S:190 E:195 ||| IN
their  ||| S:195 E:201 ||| PRP$
corresponding  ||| S:201 E:215 ||| JJ
etiology  ||| S:215 E:224 ||| JJ
such  ||| S:224 E:229 ||| JJ
as  ||| S:229 E:232 ||| IN
pneumococci  ||| S:232 E:244 ||| NN
or  ||| S:244 E:247 ||| CC
Haemophilus  ||| S:247 E:259 ||| NNP
influenzae  ||| S:259 E:270 ||| NN
and  ||| S:270 E:274 ||| CC
Pseudomonas  ||| S:274 E:286 ||| NNP
or  ||| S:286 E:289 ||| CC
enterobacteriaceae ||| S:289 E:307 ||| NN
,  ||| S:307 E:309 ||| ,
respectively ||| S:309 E:321 ||| RB
.  ||| S:321 E:323 ||| .
However ||| S:323 E:330 ||| RB
,  ||| S:330 E:332 ||| ,
the  ||| S:332 E:336 ||| DT
reality  ||| S:336 E:344 ||| NN
is  ||| S:344 E:347 ||| VBZ
more  ||| S:347 E:352 ||| RBR
complex  ||| S:352 E:360 ||| JJ
with  ||| S:360 E:365 ||| IN
aspiration  ||| S:365 E:376 ||| JJ
pneumonia ||| S:376 E:385 ||| NN
,  ||| S:385 E:387 ||| ,
pneumonia  ||| S:387 E:397 ||| NN
in  ||| S:397 E:400 ||| IN
immunocompromised  ||| S:400 E:418 ||| JJ
patient ||| S:418 E:425 ||| NN
,  ||| S:425 E:427 ||| ,
and  ||| S:427 E:431 ||| CC
pneumonia  ||| S:431 E:441 ||| NN
in  ||| S:441 E:444 ||| IN
ventilated  ||| S:444 E:455 ||| JJ
patients ||| S:455 E:463 ||| NNS
.  ||| S:463 E:465 ||| .
Culture  ||| S:465 E:473 ||| NN
in  ||| S:473 E:476 ||| IN
the  ||| S:476 E:480 ||| DT
case  ||| S:480 E:485 ||| NN
of  ||| S:485 E:488 ||| IN
nosocomial  ||| S:488 E:499 ||| JJ
pneumonia  ||| S:499 E:509 ||| NN
is  ||| S:509 E:512 ||| VBZ
especially  ||| S:512 E:523 ||| RB
important  ||| S:523 E:533 ||| JJ
to  ||| S:533 E:536 ||| TO
obtain  ||| S:536 E:543 ||| VB
the  ||| S:543 E:547 ||| DT
antibiotic  ||| S:547 E:558 ||| JJ
susceptibility  ||| S:558 E:573 ||| NN
of  ||| S:573 E:576 ||| IN
the  ||| S:576 E:580 ||| DT
infectious  ||| S:580 E:591 ||| JJ
agent  ||| S:591 E:597 ||| NN
and  ||| S:597 E:601 ||| CC
to  ||| S:601 E:604 ||| TO
adjust  ||| S:604 E:611 ||| VB
therapy ||| S:611 E:618 ||| NN
.  ||| S:618 E:620 ||| .
Moreover  ||| S:620 E:629 ||| RB
for  ||| S:629 E:633 ||| IN
immunocompromised  ||| S:633 E:651 ||| JJ
patients ||| S:651 E:659 ||| NNS
,  ||| S:659 E:661 ||| ,
the  ||| S:661 E:665 ||| DT
differential  ||| S:665 E:678 ||| JJ
diagnosis  ||| S:678 E:688 ||| NN
is  ||| S:688 E:691 ||| VBZ
much  ||| S:691 E:696 ||| RB
wider  ||| S:696 E:702 ||| JJR
looking  ||| S:702 E:710 ||| VBG
for  ||| S:710 E:714 ||| IN
viruses ||| S:714 E:721 ||| NN
,  ||| S:721 E:723 ||| ,
filamentous  ||| S:723 E:735 ||| JJ
fungi  ||| S:735 E:741 ||| NNS
and  ||| S:741 E:745 ||| CC
Pneumocystis  ||| S:745 E:758 ||| NNP
can  ||| S:758 E:762 ||| MD
be  ||| S:762 E:765 ||| VB
very  ||| S:765 E:770 ||| RB
informative ||| S:770 E:781 ||| JJ
,  ||| S:781 E:783 ||| ,
using  ||| S:783 E:789 ||| VBG
new  ||| S:789 E:793 ||| JJ
molecular  ||| S:793 E:803 ||| JJ
assays ||| S:803 E:809 ||| NN
.  ||| S:809 E:811 ||| .
